These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16120729)

  • 21. [Effectiveness of vaccinations. Vaccination goals are achieved].
    MMW Fortschr Med; 2003 Nov; 145(48):57-8. PubMed ID: 14725003
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunoreactivity of individuals in heterogenous populations and immunoprophylaxis of infectious diseases].
    Sokhin AA
    Vestn Akad Med Nauk SSSR; 1983; (5):60-4. PubMed ID: 6868806
    [No Abstract]   [Full Text] [Related]  

  • 23. Reflections on getting ahead of the curve--an infectious disease epidemiologist's view of the past and the present.
    Noah N
    Commun Dis Public Health; 2002 Jun; 5(2):94-6. PubMed ID: 12166315
    [No Abstract]   [Full Text] [Related]  

  • 24. Infectious diseases.
    Stoeckle M; Douglas RG
    JAMA; 1995 Jun; 273(21):1686-8. PubMed ID: 7752417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic vaccines for infectious and autoimmune diseases.
    Sela M
    Adv Exp Med Biol; 1996; 397():1-5. PubMed ID: 8718575
    [No Abstract]   [Full Text] [Related]  

  • 26. Infectious disease challenges in the 1990's.
    Opal SM
    Med Health R I; 1996 Mar; 79(3):100-9. PubMed ID: 8901290
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioterror, agroterror, and new diseases.
    Ambrus JL; Ambrus CM; Ambrus JL; Akhter S; Zaidi S; Rohilla R; Baig MS
    Discov Med; 2007 Jun; 7(38):82-7. PubMed ID: 18093470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHLS overview of communicable diseases 1997: results of a priority setting exercise.
    Rushdy A; O'Mahony M
    Commun Dis Rep CDR Suppl; 1998 Nov; 8(5):S1-12. PubMed ID: 9830790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Communicable diseases surveillance: highlights for 4th quarter, 2003.
    Commun Dis Intell Q Rep; 2004; 28(1):103-22. PubMed ID: 15072165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine-preventable diseases.
    J Okla State Med Assoc; 2000 Dec; 93(12):567-8. PubMed ID: 11197952
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases.
    Sautto GA; Diotti RA
    Front Immunol; 2020; 11():1670. PubMed ID: 32849578
    [No Abstract]   [Full Text] [Related]  

  • 32. Symposium on immunization. Disease status report.
    Langmuir AD
    Arch Environ Health; 1967 Oct; 15(4):470-2. PubMed ID: 6054571
    [No Abstract]   [Full Text] [Related]  

  • 33. Biomarker vaccines.
    Cohen IR
    Hum Vaccin; 2009 Sep; 5(9):637-9. PubMed ID: 19736518
    [No Abstract]   [Full Text] [Related]  

  • 34. A small jab - a big effect: nonspecific immunomodulation by vaccines.
    Benn CS; Netea MG; Selin LK; Aaby P
    Trends Immunol; 2013 Sep; 34(9):431-9. PubMed ID: 23680130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivalent minigene vaccines against infectious disease.
    An LL; Whitton JL
    Curr Opin Mol Ther; 1999 Feb; 1(1):16-21. PubMed ID: 11249678
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of vector-borne infectious diseases by human immunity against α-Gal.
    Cabezas Cruz A; Valdés JJ; de la Fuente J
    Expert Rev Vaccines; 2016 Aug; 15(8):953-5. PubMed ID: 27100121
    [No Abstract]   [Full Text] [Related]  

  • 37. [The changing pattern in infectious disease].
    Peltola H; Eskola J
    Duodecim; 1985; 101(23):2266-80. PubMed ID: 3910400
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005.
    Brotherton J; Wang H; Schaffer A; Quinn H; Menzies R; Hull B; Lawrence G; Wood J; Wood N; Rosewell A; Newall A; MacIntyre R; Macartney K; Gidding H; McIntyre P; Booy R
    Commun Dis Intell Q Rep; 2007 Jun; 31 Suppl():S1-152. PubMed ID: 17844780
    [No Abstract]   [Full Text] [Related]  

  • 39. The Sir Mark Oliphant Conferences: international frontiers of science and technology.
    Belz GT; De Groot A
    Hum Vaccin; 2008; 4(4):260-1. PubMed ID: 18682691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines of the future.
    Smith R; Renaud RC
    Nat Rev Drug Discov; 2003 Oct; 2(10):767-8. PubMed ID: 14579810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.